M2-based influenza vaccines: recent advances and clinical potential. - Wikidata - awgldk - TriplyDB

M2-based influenza vaccines: recent advances and clinical potential.

M2-based influenza vaccines: recent advances and clinical potential.

http://www.wikidata.org/entity/Q40571808

about

Fc or not Fc; that is the question: Antibody Fc-receptor interactions are key to universal influenza vaccine design.Leishmania donovani Nucleoside Hydrolase (NH36) Domains Induce T-Cell Cytokine Responses in Human Visceral Leishmaniasis.Inactivated influenza virus vaccines: the future of TIV and QIV.An Adenovirus-Vectored Influenza Vaccine Induces Durable Cross-Protective Hemagglutinin Stalk Antibody Responses in Mice.Advances in Vaccines to Prevent Viral Respiratory Illnesses in Children.Heterologous Humoral Response against H5N1, H7N3, and H9N2 Avian Influenza Viruses after Seasonal Vaccination in a European Elderly Population.Production and purification of chimeric HBc virus-like particles carrying influenza virus LAH domain as vaccine candidates.An influenza A virus vaccine based on an M2e-modified alphavirus.Universal Vaccines and Vaccine Platforms to Protect against Influenza Viruses in Humans and Agriculture.Flagellin-fused protein targeting M2e and HA2 induces potent humoral and T-cell responses and protects mice against various influenza viruses a subtypes.Characterization of Hemagglutinin Antigens on Influenza Virus and within Vaccines Using Electron Microscopy.Combination of M2e peptide with stalk HA epitopes of influenza A virus enhances protective properties of recombinant vaccine Porous Nanoparticles With Self-Adjuvanting M2e-Fusion Protein and Recombinant Hemagglutinin Provide Strong and Broadly Protective Immunity Against Influenza Virus Infections

P2860

Q30400230-293C9D2C-CB03-40A9-A143-309CEE2C77AE Q37681902-BC75EDC9-5E5A-49A5-B796-B9C8CEE4E90F Q38683726-5E3417CF-A084-43F8-8244-278D93D4189F Q40076766-F9D988D5-F064-456B-8BD1-3686397FCB98 Q40082914-1E1D2CE8-0B6F-4A6B-95E6-0382A9FDDE54 Q40120272-D5E5B469-91E3-4A30-88B5-DF74A9389FB1 Q45324976-AFB688D6-EC8F-4FC0-9F6E-7FA413664421 Q45325550-0B5AA41A-920D-4FC8-9DE0-4A8EB578D444 Q50308620-D6896D81-7931-4BDF-BF81-C87D3C5BF3BF Q54239201-212208E0-8900-4CC8-8513-84BD6D211C7B Q55689231-3889AA3D-5415-4913-92F3-E7BF593F2F8B Q56989454-298F4C67-A898-4AAF-8CC3-685EFB874C4B Q57091953-64B1AB3E-EB20-4B65-9E08-05C063B4BDE8

P2860

M2-based influenza vaccines: recent advances and clinical potential.

http://www.wikidata.org/entity/Q40571808

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

M2-based influenza vaccines: recent advances and clinical potential.

@en

type

label

M2-based influenza vaccines: recent advances and clinical potential.

@en

prefLabel

M2-based influenza vaccines: recent advances and clinical potential.

@en

P1433

Q40571808-56545613-01CF-4287-B110-F35018E37DEE

P1476

Q40571808-4DC9F796-D15D-415E-AE6B-A20D6F783AEB

P2093

Q40571808-1936226A-EF77-45A4-86D9-56F15E886591

Q40571808-53099BA6-A643-41E8-A0E2-E31818518A2E

Q40571808-54B96D39-CF5E-4519-9295-7139FB71A765

Q40571808-E3D34A7A-97BA-4BE9-90C4-E6371D503D1A

P2860

Q40571808-0308DDBE-8B84-48C6-A1CC-343AC5399DC7

Q40571808-06C88EF9-2D2E-4B8F-96D9-53F15744CD3D

Q40571808-06D32E44-6932-458C-A56F-FDF0197130CD

Q40571808-06EE925A-3680-4174-A470-01EABF13BC8B

Q40571808-07FAE8AE-7412-46E7-8A1B-37360B4CCFCF

Q40571808-0899E858-7E5D-4B04-9A06-2D8C7A1677FB

Q40571808-0A8AE78F-7AC4-4645-A2A4-5AEE45EC0C19

Q40571808-0DFA4256-C249-47FE-AA85-1AEA1A663B80

Q40571808-0FAD30A4-D841-4E90-ACF5-461B1AD1FD30

Q40571808-12BFFCBE-FDAD-49C0-955D-30A165E9F696

P304

Q40571808-4A460460-AF1B-4E0E-A986-DDD5D742FB0C

P31

Q40571808-224E0808-FCFB-4236-85BE-933D495B2185

P356

Q40571808-48C27D10-474D-47B7-9EDC-39B170632762

P433

Q40571808-F2064048-9CF8-4DC5-B014-05E79D4C21A3

P478

Q40571808-6CD7E600-A741-4D8F-B9E9-193F8D78737B

P577

Q40571808-799558E8-311F-4407-860F-21582464CBCE

P698

Q40571808-63955091-74FA-4139-A761-85C0404F0BF1

P356

14760584.2017.1240041

P1433

Expert Review of Vaccines

P1476

M2-based influenza vaccines: recent advances and clinical potential.

@en

P2093

Annasaheb Kolpe

http://www.w3.org/2001/XMLSchema#string

Bert Schepens

http://www.w3.org/2001/XMLSchema#string

Walter Fiers

http://www.w3.org/2001/XMLSchema#string

Xavier Saelens

http://www.w3.org/2001/XMLSchema#string

P2860

New world bats harbor diverse influenza A viruses

Broadly neutralizing hemagglutinin stalk-specific antibodies require FcγR interactions for protection against influenza virus in vivo

Influenza virus hemagglutinin stalk-based antibodies and vaccines

Pandemic versus epidemic influenza mortality: a pattern of changing age distribution

A mouse model for the study of contact-dependent transmission of influenza A virus and the factors that govern transmissibility

FcgammaRIV: a novel FcR with distinct IgG subclass specificity

Supplementation of H1N1pdm09 split vaccine with heterologous tandem repeat M2e5x virus-like particles confers improved cross-protection in ferrets

Sequences of mRNAs derived from genome RNA segment 7 of influenza virus: colinear and interrupted mRNAs code for overlapping proteins

Influenza virus-like particles containing M2 induce broadly cross protective immunity

Fcgamma receptors as regulators of immune responses

P304

123-136

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14760584.2017.1240041

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27653543

http://www.w3.org/2001/XMLSchema#string